Cargando…
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
BACKGROUND: Artemisinin-based combination therapy (ACT) is currently recommended as first-line treatment for uncomplicated malaria, but of concern, it has been observed that the effectiveness of the main artemisinin derivative, artesunate, has been diminished due to parasite resistance. This reducti...
Autores principales: | Jamsen, Kris M, Duffull, Stephen B, Tarning, Joel, Lindegardh, Niklas, White, Nicholas J, Simpson, Julie A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394219/ https://www.ncbi.nlm.nih.gov/pubmed/22551019 http://dx.doi.org/10.1186/1475-2875-11-143 |
Ejemplares similares
-
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
por: Jamsen, Kris M, et al.
Publicado: (2011) -
Towards optimal design of anti-malarial pharmacokinetic studies
por: Simpson, Julie A, et al.
Publicado: (2009) -
Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria
por: Adam, Ishag, et al.
Publicado: (2012) -
A robust design for identification of the Parasite Clearance Estimator
por: Jamsen, Kris M, et al.
Publicado: (2013) -
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda
por: Tarning, Joel, et al.
Publicado: (2012)